Montgomery, AL-(ENEWSPF)- Governor Robert Bentley signed legislation into law last week expanding legal protections for qualified patients who use cannabidiol-dominant extracts for therapeutic purposes. Under the legislation, House Bill 61 aka Leni’s Law, patients may possess extract preparations of CBD that also contain up to three percent THC for the treatment of a seizure-related debilitating condition. […]

To use this website, cookies must be enabled in your browser. To enable cookies, follow the instructions for your browser below. Enabling Cookies in Internet Explorer 7, 8 9 Open the Internet Browser Click Tools Internet Options Privacy Advanced Check Override automatic cookie handling For First-party Cookies and Third-party Cookies click Accept Click OK and […]

To use this website, cookies must be enabled in your browser. To enable cookies, follow the instructions for your browser below. Enabling Cookies in Internet Explorer 7, 8 9 Open the Internet Browser Click Tools Internet Options Privacy Advanced Check Override automatic cookie handling For First-party Cookies and Third-party Cookies click Accept Click OK and […]

DEVON, Pa., May 12, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today reported financial results for the quarter ended March 31, 2016, and provided an overview of recent operational highlights. “We continue to make rapid progress in our ZYN002 cannabidiol (CBD) gel […]

Medicinal and cosmetic cannabis company MGC Pharmaceuticals hopes to start selling its cannabis-based cosmetics in Australia within two to three months. While the company awaits regulatory approval in Australia, it has signed a distribution agreement in the Czech Republic and is pursuing distribution agreements for cosmetic products in Poland, Germany, France and the United States. […]

DEVON, Pa., May 12, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today reported financial results for the quarter ended March 31, 2016, and provided an overview of recent operational highlights. “We continue to make rapid progress in our ZYN002 cannabidiol (CBD) gel […]

Ever since states have started to legalize marijuana, people have debated the effects of legalization. Well, here’s one consequence: Weed has gotten cheaper in Washington since the state legalized it. According to an analysis of data from the Washington’s Liquor and Cannabis Board, the price of pot has gone down by about two percent per […]

By Dennis ThompsonHealthDay Reporter (HealthDay News) — Most doctors approach medical marijuana with a great deal of uncertainty, because drug laws have hindered researchers’ ability to figure out what pot can and can’t do for sick patients. That could soon change. The U.S. Drug Enforcement Administration (DEA) is weighing whether to loosen its classification of […]

In recent years there has been great research interest in ketamine as an antidepressant. Ketamine, a drug better-known for its use as an anaesthetic (and a recreational drug in lower doses) is claimed to have powerful, rapid-acting antidepressant effects, even in depressed patients who have not responded to more conventional drugs. However, its mechanism of […]

TUESDAY, May 10, 2016 — Most doctors approach medical marijuana with a great deal of uncertainty, because drug laws have hindered researchers’ ability to figure out what pot can and can’t do for sick patients. That could soon change. The U.S. Drug Enforcement Administration (DEA) is weighing whether to loosen its classification of marijuana, which […]

Copyright © 2016 Zacks Investment Research At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has nearly tripled the SP 500 […]